If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks61ZU.L Regulatory News (61ZU)

  • There is currently no data for 61ZU

NatWest Markets transfer scheme

6 Dec 2018 14:16

RNS Number : 7125J
Royal Bank of Scotland Group PLC
06 December 2018
 

The Royal Bank of Scotland Group

6 December 2018

The Royal Bank of Scotland Group plc - NatWest Markets transfer scheme

As previously announced, in anticipation of the UK's departure from the European Union on 29 March 2019, The Royal Bank of Scotland Group plc (together with its subsidiaries, "RBS Group") has been making its Dutch subsidiary, NatWest Markets N.V., operationally ready to serve NatWest Markets Plc customers who are incorporated or located in the European Economic Area ("EEA"). NatWest Markets N.V. is currently a subsidiary of The Royal Bank of Scotland Group plc and, subject to approvals, is expected to transfer to become a subsidiary of NatWest Markets Plc in 2019.

The RBS Group today announces that a petition (the "Petition") was presented to the Court of Session in Scotland (the "Court") on 6 December 2018 for an order under Part VII of the Financial Services and Markets Act 2000 ("FSMA") requesting approval of a Transfer Scheme (the "Scheme") for the replication of master trade documentation for non-UK European Economic Area ("EEA") customers and the transfer of certain existing transactions of EEA customers from NatWest Markets Plc to NatWest Markets N.V.

The Scheme is the approach we are taking to ensure optionality for continuity of service for non-UK EEA customers by having contracts (such as master agreements and other overarching terms of business) in place between non-UK EEA customers and NatWest Markets N.V. The Scheme is designed with two phases to provide flexibility so we can be responsive to any political changes in relation to the UK leaving the European Union, such as any agreed transitional period. Customers will be contacted directly with more detail on how they will be impacted.

A first hearing was held at the Court today and a hearing for the approval of the Scheme is expected to be held on 22 February 2019. If the Scheme is approved at that hearing, the expected effective dates would be as follows:

(i) 28 February 2019 - for Phase 1 of the Scheme, where master documentation with NatWest Markets Plc will be replicated with NatWest Markets N.V.

(ii) 04 March 2019 (or such later date between 4 March and 31 December 2019) - for Phase 2 of the Scheme which will transfer certain existing transactions for some EEA customers (as at the Phase 2 Effective Date) from NatWest Markets Plc to NatWest Markets N.V. NatWest Markets Plc and NatWest Markets N.V. will notify non-UK EEA customers should the date change from 4 March 2019 as a result of political or other developments.

Implementation of the Scheme is subject to approval from the Court and other regulatory approvals.

The Scheme impacts approximately 30% of NatWest Markets Plc's customers, who account for approximately 20% of the NatWest Markets franchise revenues. In a scenario where there is an expectation of an immediate loss of access to the European Single Market up to circa £6bn equivalent of third party assets and up to circa £7bn equivalent of third party liabilities are expected to transfer from NatWest Markets Plc to NatWest Markets N.V. During a transition period, the move of non-UK EEA customers to NatWest Markets N.V. may be more gradual and subject to further political developments.

Other transactions are expected to be transferred outside of the Scheme to NatWest Markets N.V. during 2019 (for example certain transactions with Corporate and Sovereign customers and larger non-UK EEA customers from NatWest Markets Plc, and certain Western European corporate business from National Westminster Bank Plc). No debt securities issued by NatWest Markets Plc are included in the Scheme or expected to transfer.

General information on the Brexit plan for NatWest Markets is available at natwestmarkets.com/brexit.

 

Further information on the Scheme

Copies of the full terms of the Scheme and a summary of its principal terms are available, free of charge, at natwestmarkets.com/brexit or on request from NatWest Markets at 250 Bishopsgate, London EC2M 4AA. All documents will be available until the date of the Court hearing to approve (or "sanction") the Scheme, expected to be on 22 February 2019.

Making your views known

Any person who considers that they would be adversely affected by the carrying out of the Scheme has two ways of bringing their view to the attention of the Court.

a) In writing or in person

The Court is likely to consider any objection to the Scheme, which is made in writing, or in person, to the Court at any time prior to or at the Court hearing to sanction the Scheme. Any objections made in writing to the Court should be sent to the Court of Session, Parliament House, Parliament Square, Edinburgh, EH1 1RQ. No fee is payable for making such objections.

b) Lodging formal objections with the Court

Any person has the right to lodge formal written objections (known as "Answers") with the Court. If any person wishes to lodge Answers, they should seek independent legal advice. Answers are a formal Court document which must comply with the rules of the Court and are normally prepared by Scottish legal counsel. Answers must be lodged with the Court of Session at Parliament House, Parliament Square, Edinburgh, EH1 1RQ by 25 January 2019. In addition, Answers must be accompanied by a fee to the Court.

 For Further Information Contact:

RBS Investor Relations:

Matt Waymark

Head of Investor Relations

+44 (0) 20 7672 1758

 

Richard Coombs

Head of NatWest Markets Investor Relations

+44 (0) 20 7678 1768

 

RBS Media Relations:

+44 (0) 13 1523 4205

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, and requirements, financial position, future pension funding requirements, on-going litigation and regulatory investigations, profitability, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "believes", "risk", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK annual report and accounts and interim reports and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

 

Legal Entity Identifier

The Royal Bank of Scotland Group plc

2138005O9XJIJN4JPN90

NatWest Markets Plc

RR3QWICWWIPCS8A4S074

NatWest Markets N.V.

X3CZP3CK64YBHON1LE12

National Westminster Bank Plc

213800IBT39XQ9C4CP71

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEALAKEFFPFFF
Date   Source Headline
31st Jul 20203:54 pmRNSPublication of Supplementary Reg Doc & Prospectus
31st Jul 20207:00 amRNSInterim Results 2020
11th Jun 20205:15 pmRNSPublication of Supplementary Reg Doc & Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
3rd Jun 202012:51 pmRNSPublication of Final Terms
27th May 20209:44 amRNSPublication of Final Terms
20th May 20206:27 pmRNSPublication of Final Terms
18th May 202011:24 amRNSPublication of Final Terms
15th May 20202:45 pmRNSPublication of Final Terms
14th May 20201:55 pmRNSPublication of Supplementary Prospectus
13th May 20202:14 pmRNSRegistration Document and Base Prospectus
1st May 20204:24 pmRNSPublication of Suppl.Prospcts
1st May 20207:02 amRNSQ1 Interim Management Statement
15th Apr 20202:35 pmRNSAmendment of Final Terms
14th Apr 20203:07 pmRNSPublication of Final Terms
9th Apr 20204:21 pmRNSPublication of Final Terms
7th Apr 20205:59 pmRNSPublication of Final Terms
3rd Apr 202011:14 amRNSPublication of Final Terms
1st Apr 202012:48 pmRNSPublication of Final Terms
26th Mar 202010:46 amRNSPublication of Final Terms
16th Mar 20205:14 pmRNSNatWest Markets N.V. 2019 ARA
16th Mar 20202:36 pmRNSPublication of Final Terms
24th Feb 20202:18 pmRNSPublication of Final Terms
17th Feb 20201:20 pmRNSPublication of Supplementary Prospectus
14th Feb 20207:03 amRNSAnnual Financial Report
14th Feb 20207:02 amRNSFinal Results
7th Jan 202011:09 amRNSPublication of Final Terms
27th Dec 201911:26 amRNSPublication of Final Terms
20th Dec 20197:00 amRNSPublication of Suppl.Prospcts
19th Dec 20197:00 amRNSNatWest Markets Change in Executive Directors
16th Dec 20194:42 pmRNSAmendments To Provisions Relating To Interest
6th Dec 20191:16 pmRNSPublication of Final Terms
4th Dec 20192:47 pmRNSPublication of Final Terms
2nd Dec 20193:00 pmRNSPublication of Suppl.Prospcts
29th Nov 20191:28 pmRNSAnnouncement of NatWest Markets N.V. Transfer
21st Nov 20196:29 pmRNSPublication of a Prospectus
19th Nov 20192:33 pmRNSPublication of Final Terms
4th Nov 201912:55 pmRNSPublication of Final Terms
25th Oct 20194:51 pmRNSPublication of Suppl.Prospcts
24th Oct 20197:01 amRNSQ3 Interim Management Statement
18th Oct 20192:50 pmRNSNotice of Redemption
4th Oct 20191:30 pmRNSPublication of Final Terms
13th Sep 20193:53 pmRNSPublication of Final Terms
28th Aug 20192:48 pmRNSPublication of Final Terms
2nd Aug 20192:47 pmRNSPublication of Supplementary Prospectus
2nd Aug 20197:01 amRNSInterim Results 2019
3rd Jul 20195:03 pmRNSPublication of Final Terms
2nd Jul 201912:02 pmRNSPublication of Supplementary Reg Doc & Prospectus
28th Jun 20192:45 pmRNSDividend Declaration
26th Jun 201912:32 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.